Health Economic Evaluation Of Interferon Beta 1b Versus 1a For Patients Diagnosed With Relapsing Remitting Multiple Sclerosis
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.223
https://www.valueinhealthjournal.com/article/S1098-3015(16)00291-6/fulltext
Section Title :
Neurological Disorders - Health Care Use & Policy Studies
Section Order :
1574
First Page :
A69
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00291-6&doi=10.1016/j.jval.2016.03.223